慢性中心性浆液性脉络膜视网膜病变中后部囊样黄斑变性的临床特征与转归
回顾性分析62例(83眼,平均年龄59岁,88%男性)慢性中心性浆液性脉络膜视网膜病变合并后部囊样视网膜变性(PCRD)患者,76%眼在PCRD初现时存在视网膜下液,81%接受治疗,最终37%眼PCRD完全消退,光动力疗法最有效,但最佳矫正视力无改善(P=0.354)。
要点
- 慢性中心性浆液性脉络膜视网膜病变中PCRD较常见,常伴活动性视网膜下液渗漏。
- 光动力疗法在实现PCRD完全消退方面最成功。
- 即使PCRD完全消退,最佳矫正视力也未改善。
核心结论
- PCRD是慢性中心性浆液性脉络膜视网膜病变中相对常见的表现,治疗可能有助于停止视网膜下液渗漏,但较难实现PCRD完全消退和视力改善。
研究设计与样本
- 回顾性病历回顾研究,纳入62例(83眼)慢性中心性浆液性脉络膜视网膜病变合并PCRD患者,平均年龄59岁,88%为男性。
主要发现
- 63眼(76%)在PCRD首次表现时存在视网膜下液,65眼(78%)荧光素血管造影显示活动性局灶或弥漫渗漏。
- 76眼(81%)接受治疗,最终31眼(37%)PCRD完全消退。
- 平均基线最佳矫正视力为69±19 ETDRS字母,最终为67±20 ETDRS字母(Snellen等效分别为20/40和20/50),P=0.354。
关键数值与推荐
- 光动力疗法在实现PCRD完全消退方面最成功。
临床怎么用
- 治疗可考虑用于控制视网膜下液渗漏,但应告知患者PCRD完全消退和视力改善的可能性较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess clinical characteristics and visual outcome in chronic central serous chorioretinopathy patients with posterior cystoid retinal degeneration (PCRD). METHODS: Patients' medical records were reviewed retrospectively in 62 cases (83 eyes, mean age = 59 years, 88% male). Data were collected at central serous chorioretinopathy diagnosis, at PCRD manifestation, and at final visit. All treatment modalities were reviewed. Main outcome measures were treatment efficacy in achieving PCRD resolution, and final best-corrected visual acuity. RESULTS: In 63 eyes (76%), subretinal fluid was present at first PCRD manifestation, whereas fluorescein angiography showed active focal or diffuse leakage in 65 eyes (78%). Seventy-six eyes (81%) received treatment, and PCRD had resolved completely in 31 eyes (37%) at the final visit. Photodynamic therapy was most successful in achieving a complete PCRD resolution. Best-corrected visual acuity did not improve, even after complete PCRD resolution (mean baseline best corrected visual acuity = 69 ± 19, and mean final best corrected visual acuity = 67 ± 20 ETDRS letters [20/40 and 20/50 in Snellen equivalent respectively], P = 0.354). CONCLUSION: Posterior cystoid retinal degeneration is a relatively common finding in chronic central serous chorioretinopathy, which is often accompanied by active subretinal fluid leakage. Treatment may be beneficial to stop the subretinal fluid leakage component, but is less likely to result in a complete PCRD resolution and/or a best-corrected visual acuity improvement.
引用
- Mohabati D, Hoyng CB, Yzer S, et al. CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina. 2020. PMID: 31815880. doi:10.1097/IAE.0000000000002683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。